Category-specific uncertainty modeling in clinical laboratory measurement processes

Varun Ramamohan, Yuehwern Yih, James T. Abbott, George G. Klee

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: A statement of measurement uncertainty describes the quality of a clinical assay analysis result, and uncertainty models of clinical assays can be used to evaluate and optimize laboratory protocols designed to minimize the measurement uncertainty associated with an assay. In this study, we propose a methodology to lend systematic structure to the uncertainty modeling process. Methods: Clinical laboratory assays are typically classified based on the chemical reaction involved, and therefore, based on the assay analysis methodology. We use this fact to demonstrate that uncertainty models for assays within the same category are structurally identical in all respects except for the values of certain model parameters. This is accomplished by building uncertainty models for assays belonging to two categories - substrate assays based on optical absorbance analysis of endpoint reactions, and ion selective electrode (ISE) assays based on potentiometric measurements of electromotive force. Results: Uncertainty models for the substrate assays and the ISE assays are built, and for each category, a general mathematical framework for the uncertainty model is developed. The parameters of the general framework that vary from assay to assay for each category are identified and listed. Conclusions: Estimates of measurement uncertainty from the models were compared with estimates of uncertainty from quality control data from the clinical laboratory. We demonstrate that building a general modeling framework for each assay category and plugging in parameter values for each assay is sufficient to generate uncertainty models for an assay within a given category.

Original languageEnglish (US)
Pages (from-to)2273-2280
Number of pages8
JournalClinical Chemistry and Laboratory Medicine
Volume51
Issue number12
DOIs
StatePublished - Dec 1 2013

Fingerprint

Clinical laboratories
Uncertainty
Assays
Ion-Selective Electrodes
Ion selective electrodes
Quality Control
Electromotive force

Keywords

  • Clinical assay classification
  • Clinical measurement uncertainty
  • Uncertainty modeling

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Category-specific uncertainty modeling in clinical laboratory measurement processes. / Ramamohan, Varun; Yih, Yuehwern; Abbott, James T.; Klee, George G.

In: Clinical Chemistry and Laboratory Medicine, Vol. 51, No. 12, 01.12.2013, p. 2273-2280.

Research output: Contribution to journalArticle

Ramamohan, Varun ; Yih, Yuehwern ; Abbott, James T. ; Klee, George G. / Category-specific uncertainty modeling in clinical laboratory measurement processes. In: Clinical Chemistry and Laboratory Medicine. 2013 ; Vol. 51, No. 12. pp. 2273-2280.
@article{cfc5ef981b514e7bbddedf1d926dc939,
title = "Category-specific uncertainty modeling in clinical laboratory measurement processes",
abstract = "Background: A statement of measurement uncertainty describes the quality of a clinical assay analysis result, and uncertainty models of clinical assays can be used to evaluate and optimize laboratory protocols designed to minimize the measurement uncertainty associated with an assay. In this study, we propose a methodology to lend systematic structure to the uncertainty modeling process. Methods: Clinical laboratory assays are typically classified based on the chemical reaction involved, and therefore, based on the assay analysis methodology. We use this fact to demonstrate that uncertainty models for assays within the same category are structurally identical in all respects except for the values of certain model parameters. This is accomplished by building uncertainty models for assays belonging to two categories - substrate assays based on optical absorbance analysis of endpoint reactions, and ion selective electrode (ISE) assays based on potentiometric measurements of electromotive force. Results: Uncertainty models for the substrate assays and the ISE assays are built, and for each category, a general mathematical framework for the uncertainty model is developed. The parameters of the general framework that vary from assay to assay for each category are identified and listed. Conclusions: Estimates of measurement uncertainty from the models were compared with estimates of uncertainty from quality control data from the clinical laboratory. We demonstrate that building a general modeling framework for each assay category and plugging in parameter values for each assay is sufficient to generate uncertainty models for an assay within a given category.",
keywords = "Clinical assay classification, Clinical measurement uncertainty, Uncertainty modeling",
author = "Varun Ramamohan and Yuehwern Yih and Abbott, {James T.} and Klee, {George G.}",
year = "2013",
month = "12",
day = "1",
doi = "10.1515/cclm-2013-0357",
language = "English (US)",
volume = "51",
pages = "2273--2280",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "12",

}

TY - JOUR

T1 - Category-specific uncertainty modeling in clinical laboratory measurement processes

AU - Ramamohan, Varun

AU - Yih, Yuehwern

AU - Abbott, James T.

AU - Klee, George G.

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Background: A statement of measurement uncertainty describes the quality of a clinical assay analysis result, and uncertainty models of clinical assays can be used to evaluate and optimize laboratory protocols designed to minimize the measurement uncertainty associated with an assay. In this study, we propose a methodology to lend systematic structure to the uncertainty modeling process. Methods: Clinical laboratory assays are typically classified based on the chemical reaction involved, and therefore, based on the assay analysis methodology. We use this fact to demonstrate that uncertainty models for assays within the same category are structurally identical in all respects except for the values of certain model parameters. This is accomplished by building uncertainty models for assays belonging to two categories - substrate assays based on optical absorbance analysis of endpoint reactions, and ion selective electrode (ISE) assays based on potentiometric measurements of electromotive force. Results: Uncertainty models for the substrate assays and the ISE assays are built, and for each category, a general mathematical framework for the uncertainty model is developed. The parameters of the general framework that vary from assay to assay for each category are identified and listed. Conclusions: Estimates of measurement uncertainty from the models were compared with estimates of uncertainty from quality control data from the clinical laboratory. We demonstrate that building a general modeling framework for each assay category and plugging in parameter values for each assay is sufficient to generate uncertainty models for an assay within a given category.

AB - Background: A statement of measurement uncertainty describes the quality of a clinical assay analysis result, and uncertainty models of clinical assays can be used to evaluate and optimize laboratory protocols designed to minimize the measurement uncertainty associated with an assay. In this study, we propose a methodology to lend systematic structure to the uncertainty modeling process. Methods: Clinical laboratory assays are typically classified based on the chemical reaction involved, and therefore, based on the assay analysis methodology. We use this fact to demonstrate that uncertainty models for assays within the same category are structurally identical in all respects except for the values of certain model parameters. This is accomplished by building uncertainty models for assays belonging to two categories - substrate assays based on optical absorbance analysis of endpoint reactions, and ion selective electrode (ISE) assays based on potentiometric measurements of electromotive force. Results: Uncertainty models for the substrate assays and the ISE assays are built, and for each category, a general mathematical framework for the uncertainty model is developed. The parameters of the general framework that vary from assay to assay for each category are identified and listed. Conclusions: Estimates of measurement uncertainty from the models were compared with estimates of uncertainty from quality control data from the clinical laboratory. We demonstrate that building a general modeling framework for each assay category and plugging in parameter values for each assay is sufficient to generate uncertainty models for an assay within a given category.

KW - Clinical assay classification

KW - Clinical measurement uncertainty

KW - Uncertainty modeling

UR - http://www.scopus.com/inward/record.url?scp=84889560936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889560936&partnerID=8YFLogxK

U2 - 10.1515/cclm-2013-0357

DO - 10.1515/cclm-2013-0357

M3 - Article

C2 - 23969469

AN - SCOPUS:84889560936

VL - 51

SP - 2273

EP - 2280

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 12

ER -